To support the significance of CDKN2A loss in renal cancer, we further analyzed the available TCGA data and found worst survival for ccRCC and pRCC patients with CDKN2A alteration, as compared to wild type (Figure 8). The gene discussed is CDKN2A; the disease is renal carcinoma.